1. Signaling Pathways
  2. Neuronal Signaling
  3. Beta-secretase

Beta-secretase

Beta-secretase

BACE; β-Secretase

Beta-secretase (BACE) is a transmembrane aspartic proteinase responsible for cleaving the amyloid precursor protein (APP) to generate the soluble ectodomain sAPPbeta and its C-terminal fragment CTFbeta. BACE is a major target of Alzheimer's disease (AD) therapeutics. There are two forms of the enzyme: BACE1 and BACE2.

Deposition of amyloid-β protein (Aβ) to form neuritic plaques is the characteristic neuropathology of Alzheimer's disease (AD). Aβ is generated from APP by β- and γ-secretase cleavages. BACE1 is the β-secretase and its inhibition induces severe side effects, whereas its homolog BACE2 normally suppresses Aβ by cleaving APP/Aβ at the θ-site (Phe20) within the Aβ domain.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-P2714
    SEVNLDAEFR
    SEVNLDAEFR is a substrate for BACE1.
    SEVNLDAEFR
  • HY-114234A
    TAK-070 Free base
    Inhibitor
    TAK-070 Free base is a noncompetitive and orally active BACE1 inhibitor (IC50: 3.15 μM). TAK-070 Free base can be used for research of Alzheimer’s disease (AD). TAK-070 Free base inhibits brain levels of soluble Aβ, and improves cognitive impairments in AD model.
    TAK-070 Free base
  • HY-160037
    SEW06622
    Inhibitor
    SEW06622 is a BACE-1 inhibitor with an IC50 value of 6.3 μM and can be used in Alzheimer's disease research.
    SEW06622
  • HY-138013
    PF-06663195
    Inhibitor
    PF-06663195 is a β-secretase (BACE1) inhibitor, with BACE1 CFA and BACE1 WCA IC50 values of 53 and 15 nM, respectively. PF-06663195 can be used for Alzheimer's disease research.
    PF-06663195
  • HY-U00287
    BACE-IN-1
    Inhibitor
    BACE-IN-1 (Compound 13) is a substituted lmidazo[1 ,2-a]pyridine derivative which can inhibit β-site amyloid precursor protein-cleaving enzyme (BACE) and that may be useful in the treatment of diseases in which BACE is involved, such as Alzheimer's disease.
    BACE-IN-1
Cat. No. Product Name / Synonyms Application Reactivity

BACE1

BACE2

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Beta-secretase Inhibitors
Product NameBACE1BACE2Purity    
Se-Methylselenocysteine
BACE1
 99.60%
Verubecestat
BACE1
BACE2
99.56%
LY2886721
BACE1
 99.74%
BCA
BACE1, IC50: 28 μM
BACE1, Ki: 43 μM
 99.76%
Epiberberine chloride
BACE1
 99.02%
TB-9
BACE1, IC50: 54.2 nM
 
LY2811376
BACE1
 99.89%
Lanabecestat
BACE1
 99.67%
BACE2-IN-1
BACE1, Ki: 815.1 nM
BACE2, Ki: 1.6 nM
99.4%
Elenbecestat
BACE1
 99.82%
Atabecestat
BACE1
 99.77%
Scoulerine
BACE1
 99.27%
AZD3839 free base
BACE1
 99.91%
BACE1-IN-1
BACE1
 99.02%
PF-06751979
BACE1
 99.23%
(1α,1'S,4β)-Lanabecestat
BACE1
 
LX2343
BACE1, IC50: 11.43 μM
 99.80%
Epiberberine
BACE1
 98.46%
Aloeresin D
BACE1
 99.51%
Sophoflavescenol
BACE1
 98.78%
BACE1-IN-5
BACE1
 
BACE1-IN-2
BACE1
 
BACE1-IN-4
BACE1
 
AM-6494
BACE1
 
AMG-8718
BACE1, IC50: 0.0007 μM
BACE2, IC50: 0.005 μM
BACE1/2-IN-1
BACE1
BACE2
AChE/BACE1/GSK3β-IN-1
BACE1, IC50: 20 μM
 
BACE1-IN-10
BACE1
 
AChE/BChE-IN-12
BACE1, IC50: 10.65 ± 0. μM
 
Memoquin
BACE1, IC50: 108 nM
 
BACE1-IN-14
BACE1, EC50: 0.7 μM
BACE2, EC50: 1.6 μM
BACE1-IN-11
BACE1, IC50: 72 μM
 
β-Secretase Inhibitor III
BACE1
 
OM99-2
BACE1
 
AChE-IN-82
BACE1, IC50: 2.42 μM
 
BACE1-IN-9
BACE1
 
TB-11
BACE1, IC50: 48.8 nM